Physical Distress, Emotional Status, and Quality of Life in Patients With Nasopharyngeal Cancer Complicated by Post-Radiotherapy Endocrinopathy

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 1, 2008, Pages 28-34

  Lue, Bee Horng ^a,b   Huang, Tien Shang ^a,b   Chen, Hsiu Jung ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

Endocrinopathy; Nasopharyngeal cancer; Psychological distress; Quality of life; Symptom distress

Indexed keywords

BIOLOGICAL ORGANS; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY;

ENDOCRINOPATHY; NASOPHARYNGEAL CANCER; PSYCHOLOGICAL DISTRESS; QUALITY OF LIFE; SYMPTOM DISTRESS;

TUMORS;

ADULT; AGED; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COGNITION; DISTRESS SYNDROME; EMOTION; ENDOCRINE DISEASE; FATIGUE; FEMALE; HUMAN; INSOMNIA; MALE; NASOPHARYNX CANCER; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; SELF EVALUATION; SOCIAL INTERACTION; SYMPTOM;

ADRENAL INSUFFICIENCY; ADULT; AGED; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; ENDOCRINE SYSTEM DISEASES; FEMALE; GROWTH HORMONE; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PAIN; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REGRESSION ANALYSIS; SICKNESS IMPACT PROFILE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 37049000597     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.053     Document Type: Article

References (45)

1. In: Parkin D.M., Whelan S.L., Ferlay J., et al. (Eds). Cancer incidence in five continents. Volume VII (1997), International Agency for Research on Cancer, Lyon, France
2. Health and vital statistics in the Republic of China, 2003. In: Department of Health, the Executive Yuan, Republic of China, Taipei, Taiwan; 2005. Available at: http://www.doh.gov.tw/statistic/index.htm. Accessed October 11, 2005.
3. Huang S.C., Lui L.T., and Lynn T.C. Nasopharyngeal cancer: Study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys 11 (1985) 1789-1793
4. Huang H.Y., Wilkie D.J., Schubert M.M., et al. Symptom profile of nasopharyngeal cancer patients during radiation therapy. Cancer Pract 8 (2000) 274-281
5. Huang G.S., Dai Y.T., and Huang S.C. Side effects of the patients with nasopharyngeal carcinoma during receiving radiotherapy. J Chinese Oncol Soc 3 (1987) 7-17
6. Lai Y.H., Chang J.T., Keefe F.J., et al. Symptom distress, catastrophic thinking, and hope in nasopharyngeal carcinoma patients. Cancer Nurs 26 (2003) 485-493
7. Hammerlid E., Silander E., Hornestam L., et al. Health-related quality of life three years after diagnosis of head and neck cancer-a longitudinal study. Head Neck 23 (2001) 113-125
8. Huang T.S., Lui L.T., Hsu M.M., et al. Effect of cranial irradiation on hypothalamus-pituitary function: Follow-up study one year after radiotherapy. J Formos Med Assoc 90 (1991) 652-658
9. Woo E., Lam K., Yu Y.L., et al. Temporal lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma: A distinct clinical syndrome. J Neurol Neurosurg Psychiatry 51 (1988) 1302-1307
10. Parkin A.J., and Hunkin N.M. Memory loss following radiotherapy for nasal pharyngeal carcinoma-an unusual presentation of amnesia. Br J Clin Psychol 30 (1991) 349-357
11. Lee P.W., Hung B.K., Woo E.K., et al. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry 52 (1989) 488-492
12. Huang T.S., Chen S.T., Lui L.T., et al. Early effects of cranial irradiation on hypothalamic pituitary function. J Formos Med Assoc 89 (1990) 541-547
13. Chieng P.U., Huang T.S., Chang C.C., et al. Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: SPECT studies in 34 patients. Am J Neuroradiol 12 (1991) 661-665
14. Huang T.S., Huang S.C., and Hsu M.M. A prospective study of hypothalamus pituitary function after cranial irradiation with or without radiosensitizing chemotherapy. J Endocrinol Invest 17 (1994) 615-623
15. In: Greiner A.C., and Knebel E. (Eds). Health professions education: A bridge to quality (2003), Institute of Medicine of the National Academies, Washington, DC
16. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
17. Bjordal K., de Graeff A., Fayers P.M., et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36 (2000) 1796-1807
18. Chie W.C., Hong R.L., Lai C.C., et al. Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Qual Life Res 12 (2003) 93-98
19. Beck A.T., Steer R.A., and Brown G.K. Manual for Beck Depression Inventory-II (1996), Psychological Corporation, San Antonio, TX
20. Beck A.T., Epstein N., Brown G.K., et al. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 56 (1988) 893-897
21. Beck A.T., and Steer R.A. Manual for the Beck Anxiety Inventory (1993), The Psychological Corporation, San Antonio, TX
22. Arnau R.C., Meagher M.W., Norris M.P., et al. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol 20 (2001) 112-119
23. Viljoen J.L., Iverson G.L., Griffiths S., et al. Factor structure of the Beck Depression Inventory-II in a medical outpatient sample. J Clin Psychol Med S 10 (2003) 289-291
24. Katz M.R., Kopek N., Waldron J., et al. Screening for depression in head and neck cancer. Psychooncology 13 (2004) 269-280
25. Fydrich T., Dowdall D., and Chambless D.L. Reliability and validity of the Beck Anxiety Inventory. J Anxiety Disord 6 (1992) 55-61
26. Osman A., Kopper B.A., Barrios F.X., et al. The Beck Anxiety Inventory: Reexamination of factor structure and psychometric properties. J Clin Psychol 53 (1997) 7-14
27. Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 scoring manual: EORTC Quality of Life Study Group; 1999.
28. Hsu W.C., Chan S.C., Chen Y.C., et al. Analysis of the time-related quality of life for patients with early and late stages of the nasopharyngeal carcinima after rediotherapy. [in Chinese]. Chin J Radiol 29 (2004) 137-142
29. Huguenin P.U., Taussky D., Moe K., et al. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: The importance of the target volume. Int J Radiat Oncol Biol Phys 45 (1999) 47-52
30. Cengiz M., Ozyar E., Esassolak M., et al. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys 63 (2005) 1347-1353
31. Hahn C.A., Dunn R., and Halperin E.C. Routine screening for depression in radiation oncology patients. Am J Clin Oncol 27 (2004) 497-499
32. D'Antonio L.L., Long S.A., Zimmerman G.J., et al. Relationship between quality of life and depression in patients with head and neck cancer. Laryngoscope 108 (1998) 806-811
33. Berard R.M., Boermeester F., and Viljoen G. Depressive disorders in an out-patient oncology setting: Prevalence, assessment, and management. Psychooncology 7 (1998) 112-120
34. Fowler J.M., Carpenter K.M., Gupta P., et al. The gynecologic oncology consult: Symptom presentation and concurrent symptoms of depression and anxiety. Obstet Gynecol 103 (2004) 1211-1217
35. Carroll P.V., Christ E.R., and Growth Hormone Research Society Scientific Committee. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. J Clin Endocrinol Metab 83 (1998) 382-395
36. McGauley G.A. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl 356 (1989) 70-72
37. Rosen T., Wiren L., Wilhelmsen L., et al. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol 40 (1994) 111-116
38. McMillan C.V., Bradley C., Gibney J., et al. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. Clin Endocrinol 59 (2003) 467-475
39. Hull K.L., and Harvey S. Growth hormone therapy and quality of life: Possibilities, pitfalls and mechanisms. J Endocrinol 179 (2003) 311-333
40. Maruff P., and Falleti M. Cognitive function in growth hormone deficiency and growth hormone replacement. Horm Res 64 Suppl 3 (2005) 100-108
41. Falleti M.G., Maruff P., Burman P., et al. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: A meta-analysis of the current literature. Psychoneuroendocrinology 31 (2006) 681-691
42. Arwert L.I., Deijen J.B., Muller M., et al. Long-term growth hormone treatment preserves GH-induced memory and mood improvements: A 10-year follow-up study in GH-deficient adult men. Horm Behav 47 (2005) 343-349
43. Chawla S., Mohanti B.K., Rakshak M., et al. Temporal assessment of quality of life of head and neck cancer patients receiving radical radiotherapy. Qual Life Res 8 (1999) 73-78
44. Mystakidou K., Tsilika E., Parpa E., and Vlahos L. Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Qual Life Res 14 (2005) 1825-1833
45. Heinonen H., Aro A.R., Aalto A.M., et al. Is the evaluation of the global quality of life determined by emotional status?. Qual Life Res 13 (2004) 1347-1356